Estudio comparativo en la erradicación del Helicobacter pylori: Ranitidina-citrato bismuto frente omeprazol más dos antibióticos durante 7 días

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Aims: To compare the efficacy of ranitidine bismuth citrate (RB) combined with two antibiotics during seven days in comparison with OCA-7 for treatment of Helicobacter pylori. Methods: In a randomized clinical trial 200, consecutive patients infected by Helicobacter pylori were studied prospectively. One of two regimens was given for 7 days; OCA-7 (omeprazole 20 mg b.i.d., amoxicillin 1 gr b.i.d., clarithromycin 500 mg b.i.d.) or RBCA (RB 400 b.i.d., amoxicillin 1 gr b.i.d., clarithromycin 500 mg b.i.d.). Eradication was defined as a negative breath test one month after therapy. Results: 112 male and 88 female with a mean age of 48 years (range 18-82). 100 patients were randomized to OCA-7 and 100 patients to RBCA-7. Overall 186 patients completed the treatment. Intention to-treat eradication was in the group OCA-7 of 72% and 73% in group RBCA-7. Per-protocol eradicatication was in the group OCA-7 of 78% and 77% in group RBCA-7 (p=0,3). Five patients in the group OCA-7 and nine in the group RBCA-7, had side effects, three of these patients did not complete therapy by diarrhea. Conclusions: RB with two antibiotics is as effective and safe as OCA-7 for the eradication of Helicobacter pylori.

Cite

CITATION STYLE

APA

Bujanda, L., Sánchez, A., Iriondo, C., Santos, A., Cosme, A., & Muñoz, C. (2001). Estudio comparativo en la erradicación del Helicobacter pylori: Ranitidina-citrato bismuto frente omeprazol más dos antibióticos durante 7 días. Anales de Medicina Interna, 18(7), 361–363. https://doi.org/10.4321/s0212-71992001000700004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free